ArticleClinical and translational science2021

Evobrutinib, a covalent Bruton's tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants.

Holger Scheible et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.